Incidence of non-melanoma skin cancer in patients treated with psoralen and ultraviolet A therapy

被引:4
作者
Ortiz Salvador, Jose Maria [1 ]
Perez-Ferriols, Amparo [1 ,2 ]
de Miquel, Victor Alegre [1 ,2 ]
Saneleuterio Temporal, Martina [3 ]
Vilata Corell, Juan Jose [1 ,2 ]
机构
[1] Hosp Gen Univ Valencia, Serv Dermatol, Valencia, Spain
[2] Univ Valencia, Fac Med, Valencia, Spain
[3] Hosp Univ & Politecn La Fe, Valencia, Spain
来源
MEDICINA CLINICA | 2019年 / 152卷 / 12期
关键词
PUVA therapy; Phototherapy; Skin cancer; Basal cell carcinoma; Squamous cell carcinoma; Carcinoma; 8-YEAR FOLLOW-UP; METHOXSALEN PSORALEN; PUVA TREATMENT; SQUAMOUS-CELL; EUROPEAN PUVA; RISK; PSORIASIS; PHOTOCHEMOTHERAPY; MELANOMA; PERSISTENT;
D O I
10.1016/j.medcli.2018.09.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Studies reporting incidences of non-melanoma skin cancer (NMSC) are heterogeneous, depend on the geographic area of the studied population and are often short-term. The aim of this study is to determine the incidence of NMSC in patients treated with oral PUVA therapy in the Mediterranean area. Material and methods: A retrospective, observational study was carried out with a sample of 234 patients treated with systemic PUVA between 1982 and 1996, carrying out a historical follow-up until May 2017. The incidencedensity rate of CCNM (crude and adjusted) was calculated by direct standardisation. The incidence of CCNM was compared with that reported in the general population in a similar geographical area. Results: 50 neoplasms were diagnosed in 22 patients. The prevalence of CCNM in patients treated with phototherapy was 10.3%. The mean follow-up time was 21 years. The crude-adjusted incidence density rate of CCNM was 554.4-183.9 cases/100,000 treated patients per year. The crude-adjusted incidence density rate of basal cell carcinoma was 352.3-111.2 cases/100.000 patients and of squamous cell carcinoma was 229-77.7 cases/100,000 patients. Conclusion: PUVA therapy is associated with an increased risk of CCNM inthe Mediterranean population. (C) 2018 Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:488 / 492
页数:5
相关论文
共 22 条
[1]   Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review [J].
Archier, E. ;
Devaux, S. ;
Castela, E. ;
Gallini, A. ;
Aubin, F. ;
Le Maitre, M. ;
Aractingi, S. ;
Bachelez, H. ;
Cribier, B. ;
Joly, P. ;
Jullien, D. ;
Misery, L. ;
Paul, C. ;
Ortonne, J-P ;
Richard, M-A .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 :22-31
[2]   HIGH SINGLE-DOSE EUROPEAN PUVA REGIMEN ALSO CAUSES AN EXCESS OF NONMELANOMA SKIN-CANCER [J].
BRUYNZEEL, I ;
BERGMAN, W ;
HARTEVELT, HM ;
KENTER, CCA ;
VANDEVELDE, EA ;
SCHOTHORST, AA ;
SUURMOND, D .
BRITISH JOURNAL OF DERMATOLOGY, 1991, 124 (01) :49-55
[3]   CONSENSUS DOCUMENT ON PHOTOTHERAPY: PUVA THERAPY AND NARROW-BAND UVB THERAPY [J].
Carrascosa, Jose M. ;
Gardeazbal, Jesus ;
Perez-Ferriols, Amparo ;
Alomard, Agustin ;
Manrique, Pilar ;
Jones-Caballero, Maria ;
Lecha, Mario ;
Aguilera, Jose ;
de la Cuadra, Jesus .
ACTAS DERMO-SIFILIOGRAFICAS, 2005, 96 (10) :635-658
[4]   CUTANEOUS AND OCULAR SIDE-EFFECTS OF ORAL PHOTOCHEMOTHERAPY - RESULTS OF AN 8-YEAR FOLLOW-UP-STUDY [J].
COX, NH ;
JONES, SK ;
DOWNEY, DJ ;
TUYP, EJ ;
JAY, JL ;
MOSELEY, H ;
MACKIE, RM .
BRITISH JOURNAL OF DERMATOLOGY, 1987, 116 (02) :145-152
[5]   Psoriasis, its treatment, and cancer in a cohort of finnish patients [J].
Hannuksela-Svahn, A ;
Pukkala, E ;
Läärä, E ;
Poikolainen, K ;
Karvonen, J .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 114 (03) :587-590
[6]   SKIN TUMORS IN THE EUROPEAN PUVA STUDY - 8-YEAR FOLLOW-UP OF 1,643 PATIENTS TREATED WITH PUVA FOR PSORIASIS [J].
HENSELER, T ;
CHRISTOPHERS, E ;
HONIGSMANN, H ;
WOLFF, K .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1987, 16 (01) :108-116
[7]  
Henseler T, 1984, Natl Cancer Inst Monogr, V66, P217
[8]   KERATOSES AND NON-MELANOMA SKIN TUMORS IN LONG-TERM PHOTOCHEMOTHERAPY (PUVA) [J].
HONIGSMANN, H ;
WOLFF, K ;
GSCHNAIT, F ;
BRENNER, W ;
JASCHKE, E .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1980, 3 (04) :406-414
[9]  
LASSUS A, 1981, ACTA DERM-VENEREOL, V61, P141
[10]  
Lindelöf B, 1999, BRIT J DERMATOL, V141, P108